Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

Fabien Grimaud,1 Guillaume Penaranda,2 Chloé Stavris,3 Frédérique Retornaz,3 Véronique Brunel,4 Sylvie Cailleres,4 Hervé Pegliasco,5 Jacques Le Treut,5 Vincent Grisoni,6 Emilie Coquet,1 Laurent Chiche,3 Amélie Rognon1 1Department of Pharmacy, Hôpital Européen, Marseille, France; 2Department of Biost...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Grimaud F, Penaranda G, Stavris C, Retornaz F, Brunel V, Cailleres S, Pegliasco H, Le Treut J, Grisoni V, Coquet E, Chiche L, Rognon A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
immunotherapy
elderly
pd-1 inhibitor
pdl-1 inhibitor
safety
immune-related adverse events
solid tumours
prognostic biomarkers.
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/cf0fa7d1c6224b17bb4974e05a1f4225
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/cf0fa7d1c6224b17bb4974e05a1f4225

Ejemplares similares